retatrutide for women side effects Guide: 21 Proven Remedies That Work What side effects are reported

Box 1: Recent Trump Administration Obesity Drug Initiatives In November 2025, the Trump administration announced reaching a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1s for Medicare, Medicaid, and those purchasing the drugs directly from the manufacturers through a new TrumpRx website

Retatrutide is a next-generation triple receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors, making it one of the most studied compounds in modern metabolic peptide research

Some lifestyle habits may also help keep you more regular while taking this medication

Key Considerations The medications are compounded formulations , not FDA-approved brand-name products

Do GLP-1 Receptor Agonists Increase the Risk of Breast Cancer